Clinical Trials Directory

Trials / Unknown

UnknownNCT06143930

Blood Flow Restriction Training in Multiple Sclerosis

(Effect of Blood Flow Restriction Training on Muscle Strength and Gait Performance in Multiple Sclerosis Patients).

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Traditional physical therapy resisted training for people with MS have been shown to be beneficial; however, their usefulness has been limited by fatigue. The effect of blood flow restriction on strength and other measures of physical function was demonstrated in healthy populations and those with chronic disease. This study may add missing information to the existing literature and suggests directions for research on the effectiveness of BFR training on individuals with relapsing and remitting MS.

Detailed description

Multiple sclerosis patients are characterized by impaired functional capacity which is related to reduce muscle strength affecting predominantly the lower extremity. Resistance training (RT) has proven to be one of the interventions in MS patients showing a consistent and positive effect on muscle strength and on parameters directly related to lower extremity physical function (eg, walking performance and stair negotiation). Training with blood flow restriction (BFR), is an increasingly common clinical intervention among physical therapists over the past decade and consistent with the evidence. It has been investigated in people with neurological disorders including stroke and incomplete Spinal Cord Injuries. Research is limited on the use of BFR for individuals with MS.

Conditions

Interventions

TypeNameDescription
OTHERstrengthening ex with BFR trainingTherapeutic strengthening training with blood flow restriction of trained limb.
OTHERstrengthening exTherapeutic strengthening training program for lower extremities.

Timeline

Start date
2023-07-01
Primary completion
2024-04-01
Completion
2024-07-01
First posted
2023-11-22
Last updated
2023-11-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06143930. Inclusion in this directory is not an endorsement.